Your browser doesn't support javascript.
loading
The combined action of the intracellular regions regulates FGFR2 kinase activity.
Lin, Chi-Chuan; Wieteska, Lukasz; Poncet-Montange, Guillaume; Suen, Kin Man; Arold, Stefan T; Ahmed, Zamal; Ladbury, John E.
Afiliação
  • Lin CC; School of Molecular and Cellular Biology, and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, LS2 9JT, UK.
  • Wieteska L; School of Molecular and Cellular Biology, and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, LS2 9JT, UK.
  • Poncet-Montange G; Center for the Development of Therapeutics, Broad Institute of MIT & Harvard, Cambridge, MA, 02142, USA.
  • Suen KM; School of Molecular and Cellular Biology, and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, LS2 9JT, UK.
  • Arold ST; King Abdullah University of Science and Technology, Computational Bioscience Research Center, Division of Biological and Environmental Sciences and Engineering, Thuwal, 23955-6900, Saudi Arabia.
  • Ahmed Z; Centre de Biochimie Structurale, CNRS, INSERM, Université de Montpellier, 34090, Montpellier, France.
  • Ladbury JE; Department of Molecular and Cellular Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX, 77030, USA.
Commun Biol ; 6(1): 728, 2023 07 14.
Article em En | MEDLINE | ID: mdl-37452126
ABSTRACT
Receptor tyrosine kinases (RTKs) are typically activated through a precise sequence of intracellular phosphorylation events starting with a tyrosine residue on the activation loop (A-loop) of the kinase domain (KD). From this point the mono-phosphorylated enzyme is active, but subject to stringent regulatory mechanisms which can vary dramatically across the different RTKs. In the absence of extracellular stimulation, fibroblast growth factor receptor 2 (FGFR2) exists in the mono-phosphorylated state in which catalytic activity is regulated to allow rapid response upon ligand binding, whilst restricting ligand-independent activation. Failure of this regulation is responsible for pathologic outcomes including cancer. Here we reveal the molecular mechanistic detail of KD control based on combinatorial interactions of the juxtamembrane (JM) and the C-terminal tail (CT) regions of the receptor. JM stabilizes the asymmetric dimeric KD required for substrate phosphorylation, whilst CT binding opposes dimerization, and down-regulates activity. Direct binding between JM and CT delays the recruitment of downstream effector proteins adding a further control step as the receptor proceeds to full activation. Our findings underscore the diversity in mechanisms of RTK oligomerisation and activation.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tirosina / Receptor Tipo 2 de Fator de Crescimento de Fibroblastos Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tirosina / Receptor Tipo 2 de Fator de Crescimento de Fibroblastos Idioma: En Ano de publicação: 2023 Tipo de documento: Article